Orange Peel Compound Plant Beverage improving nonalcoholic fatty liver disease through anti-inflammatory and antioxidant factors and gut microbiota in rat model
Key Points
Improvement in nonalcoholic fatty liver disease was observed with dietary intake of the orange peel beverage, indicating its therapeutic potential.
The study showed a significant decrease in liver inflammation and oxidative stress markers, with a notable 40% reduction observed after treatment.
Analysis using a rat model demonstrated how the orange peel compound influences gut microbiota composition, impacting overall liver health and inflammation signals.
Highlighting the potential of using natural dietary products, this finding suggests further exploration for human applications may be beneficial.